Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for pain in Sickle Cell Disease
NCT01849016Phase 3Completed
- Sponsor
- University of Amsterdam
- Start
- Apr 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in sickle cell disease (SCD) comparing N-Acetylcysteine with Placebo (2 arms). Primary endpoint: The incidence rate of SCD related pain in daily life per patient year at 6 months. Started Apr 2013; status: completed.
02
Drugs
acetylcysteine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01849016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849016.